Código QR (código de barras bidimensional)

Facial Dysmorphism: An Unreported Teratogenicity with Levetiracetam

Levetiracetam (LEV) is a relatively newer anticonvulsant drug used to treat epilepsy and is approved by United States Food and Drugs Administration (USFDA). The drug binds to a synaptic vesicle glycoprotein and inhibits presynaptic calcium channels, thus reducing neurotransmitter release. Commonly...

ver descrição completa

Na minha lista:
Principais autores: Jyotsana Gupta, Sandhya Jain, Shalini Rajaram, Neerja Goel, Bindiya Gupta
Formato: Artigo
Idioma:Inglês
Publicado em: JCDR Research and Publications Private Limited 2017-01-01
coleção:Journal of Clinical and Diagnostic Research
Assuntos:
antiepileptic drugs
bifid vertebra
category c drug
facial dysmorphism
Acesso em linha:https://jcdr.net/articles/PDF/9269/23824_CE[Ra1]_F(DK)_PF1(DK_NE)_PFA_NC(DK)_PF2(SH_DK).pdf
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados